Aulos Bioscience Appoints Aron Knickerbocker as CEO
News provided by
Share this article
Share this article
BOSTON and TEL AVIV, Israel, March 15, 2021 /PRNewswire/ Aulos Bioscience, a biotechnology company that is developing highly differentiated interleukin-2 (IL-2)-binding monoclonal antibodies as therapeutics against solid tumors, announced today that Aron Knickerbocker has joined the company as its chief executive officer and a member of its board of directors, effective immediately. Yanay Ofran, Ph.D., CEO of Biolojic Design and co-founder and founding CEO of Aulos, will continue to serve on the Aulos board.
Aulos was formed late last year by ATP, a leading life sciences venture capital firm, and Biolojic Design, a biotechnology company that computationally designs functional antibodies. With the addition of Aron Knickerbocker as CEO, we are building a world-class organization with deep experience in bringing breakthrough medicines to cancer patients. Aron s record of ac
Zoo-Momente für die Ohren
tierwelt.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tierwelt.ch Daily Mail and Mail on Sunday newspapers.
FIVE PRIME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Five Prime Therapeutics - FPRX
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.
PharmiWeb.com is Europe s leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.4.7.1
You are leaving PharmiWeb.com
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.